AGN nah thanks don’t own, sold it and there are a multiple reasons why due to its glutamate issues and past drugs in the past decades reporting the same issues with glutamate and safety in large cohorts. You should check what NA-1 CEO stated about safety in large cohorts. But great thing about AGN it proves up the main mechanism of action
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $52.72M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 26.5¢ | 23.5¢ | $208.1K | 848.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 44240 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 37500 | 1 |
View Market Depth
| Last trade - 11.27am 18/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |